nicotine has been researched along with Basal Ganglia Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL | 1 |
| Manderscheid, PZ; Montgomery, SP; Moss, DE; Norman, AB; Sanberg, PR | 1 |
| Bonta, IL; De Vos, CJ; Grijsen, H; Hillen, FC; Noach, EL; Sim, AW | 1 |
2 review(s) available for nicotine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Dopamine; Health Care Costs; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1999 |
Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Cannabinoids; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Tourette Syndrome | 1989 |
1 other study(ies) available for nicotine and Basal Ganglia Diseases
| Article | Year |
|---|---|
1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.
Topics: Acoustic Stimulation; Amines; Amphetamine; Animals; Basal Ganglia Diseases; Behavior, Animal; Brain Chemistry; Cats; Corpus Striatum; Dogs; Dopamine; Electroencephalography; Exploratory Behavior; Hepatectomy; Male; Mice; Motor Activity; Movement Disorders; Nicotine; Pyrrolidinones; Rabbits; Rats; Reflex; Strychnine; Tremor; Tremorine | 1971 |